MedPath
NMPA Approval

Voriconazole for Oral Suspension

国药准字HJ20250023

March 4, 2025

Drug Information

伏立康唑干混悬剂

口服混悬剂

45g:3g,配制成混悬液后伏立康唑浓度为40mg/ml

化学药品

March 4, 2025

March 3, 2030

Company Information

Applicant Company

UNIT-V, SY.NO.439, 440, 441 & 458, TSIIC FORMULATION SEZ, POLEPALLE VILLAGE, JADCHERLA MANDAL, MAHABUBNAGAR DISTRICT, PINCODE 509301, TELANGANA STATE, INDIA

Manufacturing Company

UNIT-V, SY.NO.439, 440, 441 & 458, TSIIC FORMULATION SEZ, POLEPALLE VILLAGE, JADCHERLA MANDAL, MAHABUBNAGAR DISTRICT, PINCODE 509301, TELANGANA STATE, INDIA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.